Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

TRIB

Trinity Biotech Plc ADR

Apr 10 • 04:00PM ET

0.7143

+0.0167 2.39 %

Healthcare • Medical Devices • Ireland • NASD

Peers: ABT TMO BIO DGX HOLX QDEL LH OSUR NTRA MMSI

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.35	Insider Own	3.57%	Shs Outstand	18.63M	Perf Week	18.46%
Market Cap	13.31M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	17.97M	Perf Month	-0.79%
Enterprise Value	129.17M	PEG	-	EPS next Q	-	Inst Own	4.56%	Short Float	1.62%	Perf Quarter	-3.76%
Income	-36.80M	P/S	0.27	EPS this Y	-	Inst Trans	-15.25%	Short Ratio	1.18	Perf Half Y	-32.61%
Sales	48.54M	P/B	-	EPS next Y	-	ROA	-36.02%	Short Interest	0.29M	Perf YTD	-9.70%
Book/sh	-2.94	P/C	9.93	EPS next 5Y	-	ROE	-	52W High	3.44 -79.24%	Perf Year	27.55%
Cash/sh	0.07	P/FCF	-	EPS past 3/5Y	- 23.88%	ROIC	-61.18%	52W Low	0.50 42.52%	Perf 3Y	-82.89%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-12.85% -7.43%	Gross Margin	34.44%	Volatility	11.35% 10.97%	Perf 5Y	-96.19%
Dividend TTM	-	EV/Sales	2.66	EPS Y/Y TTM	-3.53%	Oper. Margin	-27.24%	ATR (14)	0.07	Perf 10Y	-98.74%
Dividend Ex-Date	Jun 05, 2015	Quick Ratio	0.47	Sales Y/Y TTM	-18.00%	Profit Margin	-75.80%	RSI (14)	57.47	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.03	EPS Q/Q	40.37%	SMA20	10.93%	Beta	0.92	Target Price	15.00
Payout	-	Debt/Eq	-	Sales Q/Q	-5.97%	SMA50	0.77%	Rel Volume	0.99	Prev Close	0.70
Employees	-	LT Debt/Eq	-	Earnings	-	SMA200	-21.59%	Avg Volume	246.53K	Price	0.71
IPO	Oct 21, 1992	Option/Short	Yes / Yes	EPS/Sales Surpr.	-311.83% -3.90%	Trades		Volume	243,576	Change	2.39%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-23-15	Downgrade	Craig Hallum	Buy → Hold
Sep-03-15	Initiated	Raymond James	Outperform
Jul-29-15	Reiterated	ROTH Capital	Buy	$22 → $20
Jul-22-08	Reiterated	Roth Capital	Buy	$7 → $6
Mar-17-08	Reiterated	Roth Capital	Buy	$10.50 → $7
Dec-10-07	Reiterated	Roth Capital	Buy	$11.50 → $10.50
Oct-26-07	Reiterated	Roth Capital	Buy	$13 → $11.50

Mar-23-26 09:23AM	Trinity Biotech Announces Successful Clinical Results for Its Enhanced EpiCapture Prostate Cancer Test (GlobeNewswire) -5.14%
Mar-18-26 08:30AM	Trinity Biotech Announces Collaboration with University at Buffalo to Commercialize Novel Biomarkers for Sjogren's Syndrome (GlobeNewswire) -7.03%
Mar-12-26 09:00AM	Trinity Biotech Begins Rollout of Innovative Glucose Monitoring System In Key Market Following Regulatory Approval of Next-Generation Premier Hb9210 HbA1c Column System (GlobeNewswire)
Mar-11-26 09:00AM	Trinity Biotech Senior Executives to Attend ATTD 2026 to Advance Collaborations Following Strong Progress in CGM Program (GlobeNewswire) +10.04%
Mar-10-26 07:55AM	Trinity Biotech Announces Further Major Technical Breakthroughs in Advancing Next Generation CGM+ Platform (GlobeNewswire) -6.66%
07:45AM	Loading…
07:45AM	Trinity Biotech Provides Business and Trading Update (GlobeNewswire)
Feb-25-26 09:00AM	Trinity Biotech Secures $25 Million Financing Commitment to Support Growth Initiatives (GlobeNewswire)
Feb-20-26 05:00PM	Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares (GlobeNewswire)
Feb-13-26 05:00PM	Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Nasdaq Minimum Bid Price Requirement (GlobeNewswire)
Feb-10-26 01:28PM	Trinity Biotech Secures Regulatory Approval for Commencement of Upstream Manufacturing Activities of Uni-Gold HIV Rapid Test Under Its Offshored and Outsourced Model, Supporting Financial Performance Transformation (GlobeNewswire) +8.75%
08:00AM	Trinity Biotech Glucose Monitoring Innovation Achieves Unique Global Recognition: Diabetes Care Premier Hb9210 HbA1c Analyser Becomes the Only System Awarded Prestigious IFCC Gold Classification for 2026 (GlobeNewswire)
Dec-23-25 11:45AM	Trinity Biotech Stock Jumps 60% After Major Breakthrough (GuruFocus.com) +43.50%
08:50AM	Trinity Biotech Announces Agreements to Strengthen Capital Structure and Support Growth Initiatives (GlobeNewswire)
07:32AM	Trinity Biotech Awarded a Major Order for 9 Million TrinScreen HIV Tests (GlobeNewswire)
Dec-15-25 09:15AM	Trinity Biotech Expands Global Rollout of High-Capacity Column System for FDA-Cleared HbA1c Testing Solution After Securing Regulatory Clearances (GlobeNewswire) -12.15%
09:00AM	Loading…
Nov-18-25 09:00AM	Trinity Biotech Secures Major Regulatory Approval for Offshored and Outsourced Manufacturing of Its Market Leading Uni-Gold Rapid HIV Test, Further Accelerating Financial Performance Transformation (GlobeNewswire)
Nov-14-25 09:00AM	Trinity Biotech Announces Collaboration to Advance Epigenetic Analysis for EpiCapture Prostate Cancer Test (GlobeNewswire)
Oct-27-25 09:00AM	Trinity Biotech Welcomes Perceptive Advisor's Indication of Potential Debt-to-Equity Conversion - Strengthening Balance Sheet and Supporting Growth (GlobeNewswire)
Sep-02-25 09:30AM	Trinity Biotech Regains Compliance with Nasdaq Listing Requirements (GlobeNewswire)
Aug-21-25 09:00AM	Trinity Biotech Appoints Paul Tivnan as Non-Executive Director (GlobeNewswire) -10.34%
Aug-20-25 09:00AM	Regulatory Approval Granted for Commencement of Trinity Biotech's Offshored and Outsourced Manufacturing of its Flagship Rapid HIV Test, Facilitating Strategic and Financial Performance Transformation (GlobeNewswire) +27.01%
Aug-15-25 10:00AM	Trinity Biotech's Redesigned CGM Sensor Favored by New Clinical Data (Zacks) -15.18%
Aug-14-25 09:00AM	Trinity Biotech Receives Regulatory Approval to Begin FDA-Cleared PreClara Preeclampsia Testing Service (GlobeNewswire) +89.05%
Aug-12-25 08:45AM	Trinity Biotech Achieves Breakthrough Clinical Trial Results for Redesigned CGM Sensor (GlobeNewswire) +35.59%
Aug-07-25 08:00AM	Trinity Biotech Announces Launch of FDA-cleared Preeclampsia Testing Service (GlobeNewswire) +7.41%
Jul-24-25 08:20AM	Trinity Biotech Unveils CGM+: An AI-Native Platform Targeting the $260 Billion AI Wearable Market (GlobeNewswire)
Jul-01-25 09:00AM	Trinity Biotech Reaches Profitability Inflection Point, Marking Major Milestone in Strategic Turnaround (GlobeNewswire) +7.42%
Jun-24-25 08:00AM	Trinity Biotech Secures Key Regulatory Approval for Offshored and Outsourced Manufacturing of Its Flagship Rapid HIV Test, Accelerating Strategic & Financial Performance Transformation (GlobeNewswire) +27.04%
May-15-25 04:00PM	Trinity Biotech Publishes Fourth Quarter and Fiscal Year 2024 Financial Results & Provides a Business Update (GlobeNewswire)
Mar-14-25 04:30PM	Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares and Nasdaq Minimum Bid Price Requirement (GlobeNewswire)
07:30AM	Loading…
Mar-13-25 07:30AM	Trinity Biotech Further Strengthens Focus on Continuous Glucose Monitoring - Appoints Barclays to Advise on Ongoing Strategic Realignment Process (GlobeNewswire)
Feb-28-25 08:30AM	Trinity Biotech Announces Additional Funding To Support Transformation Plan & Continued Development of the Company's Continuous Glucose Monitoring Technology (GlobeNewswire)
Feb-06-25 07:30AM	Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial (GlobeNewswire) -7.19%
Jan-28-25 07:20AM	Trinity Biotech Announces Breakthrough Results From Pre-Pivotal Trial of Disruptive Continuous Glucose Monitoring (CGM) Technology (GlobeNewswire) +78.95%
Dec-24-24 08:33AM	Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation Plan (GlobeNewswire) -7.75%
Dec-18-24 11:00AM	Trinity Biotech Receives Early Approval from the World Health Organization to Begin Offshore Manufacturing of TrinScreen HIV & Uni-Gold HIV (GlobeNewswire)
Nov-16-24 02:03AM	Trinity Biotech PLC (TRIB) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ... (GuruFocus.com)
Nov-15-24 09:00AM	Trinity Biotech Announces Q3 2024 Financial Results (GlobeNewswire) -7.43%
Nov-14-24 08:07AM	Trinity Biotech to Announce Q3 2024 Financial Results (GlobeNewswire)
Nov-07-24 08:19AM	Trinity Biotech Regains Compliance with Nasdaq Listing Requirements (GlobeNewswire)
Oct-25-24 08:45AM	Trinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCapture (GlobeNewswire) +5.46%
08:45AM	Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform (GlobeNewswire)
Oct-09-24 06:23PM	Trinity Biotech PLC (TRIB) Q2 2024 Earnings Call Highlights: Strong Point-of-Care Growth Amidst ... (GuruFocus.com) +11.25%
Oct-07-24 08:15AM	Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology (GlobeNewswire) +13.33%
Sep-26-24 06:28AM	Trinity Biotech Acquires Preeclampsia Prediction Firm (TipRanks)
Sep-24-24 04:05PM	Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health Market (GlobeNewswire)
Sep-18-24 04:05PM	Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with Bayer (GlobeNewswire) -6.25% -14.67%
Sep-09-24 04:05PM	Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor Technology (GlobeNewswire)
Sep-03-24 09:55AM	Trinity Biotech Appoints Global Life Sciences Leader as Chief Commercial Officer (GlobeNewswire) -9.55%
Aug-27-24 08:55AM	Why Is Clinical Diagnostics Focused Trinity Biotech Stock Trading Higher On Tuesday? (Benzinga) +23.15%
Aug-26-24 04:05PM	Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 Sales (GlobeNewswire)
Aug-20-24 05:00PM	Trinity Biotech Appoints Diabetes Care Veteran as Biosensor Marketing Director (GlobeNewswire) -5.32%
Aug-14-24 07:30AM	Trinity Biotech Announces Q2 2024 Financial Results (GlobeNewswire)
Aug-13-24 04:05PM	Trinity Biotech to Announce Q2 2024 Financial Results (GlobeNewswire)
Aug-06-24 04:05PM	Trinity Biotech Obtains an Extension to Demonstrate Compliance With Nasdaq Listing Requirements (GlobeNewswire) -10.97%
Aug-02-24 09:24AM	Trinity Biotech Provides Preliminary Second Quarter 2024 Update and Enters into UK Distribution Agreement with MedScience (GlobeNewswire)
Jul-09-24 04:05PM	Trinity Biotech Announces Appointment of A New CFO (GlobeNewswire) +13.55% +18.52%
Jun-24-24 07:00AM	Trinity Biotech to Begin European Pre-Pivotal Trial to Optimize its CGM Sensor (GlobeNewswire)
Jun-10-24 09:10AM	Trinity Biotech Attending 84th Scientific Sessions of the American Diabetes Association (GlobeNewswire) +8.57%
Jun-03-24 04:00AM	Trinity Biotech Launches its Continuous Glucose Monitoring Microsite to Showcase its Innovative & Differentiated Technology (GlobeNewswire)
May-23-24 12:53PM	TRIB Stock Earnings: Trinity Biotech Reported Results for Q1 2024 (InvestorPlace)
08:00AM	Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance (GlobeNewswire)
May-21-24 04:05PM	Trinity Biotech plc to Announce Q1 2024 Financial Results (GlobeNewswire)
May-16-24 09:18AM	Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAI (GlobeNewswire)
May-13-24 01:30PM	Trinity Biotech Secures Additional Orders For TrinScreen HIV Rapid Test Product (MT Newswires) -7.06%
11:42AM	Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance for 2024 TrinScreen HIV Sales (GlobeNewswire)
May-08-24 10:36AM	Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Development (GlobeNewswire)
Apr-08-24 09:23AM	Trinity Biotech plc (NASDAQ:TRIB) Q4 2023 Earnings Call Transcript (Insider Monkey)
Apr-05-24 05:45PM	Trinity Biotech PLC (TRIB) Q4 2023 Earnings Call Transcript Highlights: A Glimpse into ... (GuruFocus.com)
Apr-04-24 11:52AM	TRIB Stock Earnings: Trinity Biotech Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
07:30AM	Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates (GlobeNewswire)
Mar-28-24 06:39PM	Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results (GlobeNewswire)
Mar-08-24 10:03AM	Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule (GlobeNewswire)
Mar-06-24 07:00AM	Presenting on the Emerging Growth Conference 68 Day 2 on March 7 Register Now (GlobeNewswire)
Mar-05-24 07:00AM	Presenting on the Emerging Growth Conference 68 Day 1 on March 6 Register Now (GlobeNewswire)
Feb-15-24 12:34PM	Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change (GlobeNewswire)
Feb-13-24 09:00AM	Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change (GlobeNewswire)
Feb-08-24 08:30AM	Trinity Biotech to Present at Emerging Growth Conference (GlobeNewswire)
Feb-07-24 08:30AM	Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA Code (GlobeNewswire) -8.60%
Feb-02-24 07:26AM	Trinity Biotech (TRIB) to Grow in Wearable Biosensor With Buyout (Zacks) +6.31%
Jan-31-24 07:05AM	Trinity Biotech Announces Q3 2023 Financial Results & Business Update (GlobeNewswire) +35.66%
07:02AM	Trinity Biotech Announces Entry into a Letter of Intent with Bayer for a Joint Partnership to Launch a CGM Biosensor Device in China and India (GlobeNewswire)
07:00AM	Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc. (GlobeNewswire)
Jan-30-24 05:23PM	Trinity Biotech plc to Host Investor Call (GlobeNewswire)
Dec-27-23 08:57AM	Trinity Biotech Announces It Has Begun Shipments of Its New HIV Screening Test, TrinScreen HIV to Kenya (GlobeNewswire)
Dec-18-23 04:30PM	Trinity Biotech Announces Management Changes (GlobeNewswire)
Nov-28-23 04:05PM	Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares (GlobeNewswire) +14.59% +7.48%
Oct-10-23 08:15AM	Trinity Biotech Welcomes The Decision Of The High Court Of Kenya To Strike Out The Applications To Prevent the Procurement of TrinScreen HIV By The Kenyan Ministry of Health (GlobeNewswire) +7.91%
Oct-05-23 08:15AM	Trinity Biotech plc (NASDAQ:TRIB) Q2 2023 Earnings Call Transcript (Insider Monkey) -13.37%
Oct-03-23 09:15AM	Trinity Biotech Announces Q2 2023 Financial Results (GlobeNewswire)
Sep-27-23 12:50PM	Trinity Biotech plc to Announce Second Quarter Fiscal Year 2023 Financial Results (GlobeNewswire)
Sep-11-23 04:50PM	Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Minimum Bid Price Requirement (GlobeNewswire) +21.06% -5.66%
Aug-28-23 11:48AM	Trinity Biotech PLC (TRIB): A Comprehensive Analysis of Its Market Value (GuruFocus.com) +6.50%
Aug-07-23 08:00AM	Trinity Biotech Announces That It Has Received 510(k) Clearance From The U.S. Food and Drug Administration for the Premier Resolution System (GlobeNewswire) -16.78%
Jul-12-23 06:04AM	Bearish: This Analyst Is Revising Their Trinity Biotech plc (NASDAQ:TRIB) Revenue and EPS Prognostications (Simply Wall St.)
Jul-06-23 09:45AM	Trinity Biotech Announces Q1 2023 Financial Results (GlobeNewswire) -13.10%
09:26AM	There Is A Reason Trinity Biotech plc's (NASDAQ:TRIB) Price Is Undemanding (Simply Wall St.)
Jul-03-23 06:30PM	Trinity Biotech plc to Announce First Quarter Fiscal Year 2023 Financial Results (GlobeNewswire) +10.26%
Jun-03-23 08:52AM	Calculating The Intrinsic Value Of Trinity Biotech plc (NASDAQ:TRIB) (Simply Wall St.)
May-05-23 08:00AM	Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule (GlobeNewswire)

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TRIB

Trinity Biotech Plc ADR

Upgrade your Finviz experience